Results indicated that NCOR2, APH1B, ELF3, HDAC4, MYC, and TLE2 exhibited higher expressions, FZD5, GZMB, HEY2, PSMA2, PSMA3, PSMA4, PSDM1, and SKP2 exhibited lower expressions in HCC patients (Figure 9A). This evidence concerns the gene PSMA3 and hepatocellular carcinoma.